Posts tagged as

SBIR

Study of Innovative Cancer Radiation Response Blood Test Opens at UF

While radiation is required by 70 percent of cancer patients, there is currently no reliable methodology for determining its adverse effects during treatment. A clinical study at UF is aiming to change this. Blood specimens are being collected and analyzed from up to 500 patients undergoing radiotherapy for prostate cancer…

Radiation Oncology Teams Study Innovative Cancer Radiation Response Blood Test

Paul Okunieff, MD, Chair of the Department of Radiation Oncology at the UF College of Medicine, and the University of Florida Health Cancer Center Radiation Oncology team will continue development of a radiation toxicity biomarker through a $2 million National Cancer Institute (NCI) Small Business Innovation Research (SBIR) contract. The…

NATIONALLY RANKED

U.S. News and World Report

Nationally ranked in 6 adult specialties and 6 pediatric specialties and rated high performing in 4 adult specialties and 5 procedures and conditions.

Award